EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Characterization of Pulmonary Functional Abnormalities in Systemic Sclerosis Using Xenon MRI

Dawson Shaver, Steven Haworth iD, Evan Graumann, Bradie Frizzell, David H Lee, Jiwoong Choi iD, Chase S Hall, Scott M Matson, Mark Hamblin, Mario Castro iD, Paul S Schmidt, Peter J Niedbalski iD

Journal of Magnetic Resonance Imaging · 2026-09 · 64 (3) · 655-666

DOI: 10.1002/jmri.70363 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, online erschienen am 06.05.2026. Verfasst von Dawson Shaver und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, …. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Magnetic Resonance Imaging, Xenon, Lung. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: American Heart Association, National Scleroderma Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Xenon MRI is increasingly used to evaluate patients with interstitial lung disease (ILD) and pulmonary hypertension (PH), both of which are common manifestations of systemic sclerosis (SSc). As such, Xe‐MRI may be suited to interrogate lung function impairment in SSc.

Purpose

To characterize xenon MRI signatures in SSc, toward evaluating the utility of xenon MRI as a method to elucidate mechanisms of regional lung function impairment in this population. Study Type Prospective. Population Of 25 participants initially imaged, 21 participants (18 females) with SSc were included. Sixteen healthy volunteers (13 females) were enrolled. Fieldstrength/Sequence 3 T, 1‐point Dixon imaging using xenon MRI. Assessment Xenon MRI measures including ventilation defect percent, membrane uptake, red blood cell (RBC) transfer, RBC defect percent, and RBC oscillation amplitude were generated. Measures were compared across healthy and SSc groups and correlated with standard clinical measures, including demographics, pulmonary function tests, CT lung density measures, and pulmonary artery pressure. Statistical Tests Due to a small number of male participants, statistical analysis was limited to female participants. Wilcoxon, t ‐tests, or Fisher's exact tests were used to compare between healthy and SSc groups. Pearson's correlation was used to correlate xenon MRI with clinical measures. p < 0.05 was considered significant.

Results

Despite a relatively mild burden of pulmonary disease, SSc participants exhibited significantly lower RBC/Membrane ratio (0.25 [IQR, 0.10] vs. 0.34 [0.05]) and RBC transfer (0.22 ± 0.07 vs. 0.28 ± 0.07), and significantly greater RBC defect percent (22.8 [IQR, 16.9] vs. 11.9 [13.7]) compared to healthy volunteers. Data Conclusion Xenon MRI measures, including RBC transfer, RBC/Membrane, and RBC defect percent were markedly different in female SSc patients compared to age‐matched healthy volunteers, suggesting that xenon MRI may be an effective method for examining regional impairments to pulmonary gas exchange in SSc. Evidence Level 2. Technical Efficacy Stage 2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, SystemicMagnetic Resonance ImagingXenonLungLung Diseases, InterstitialHumansFemaleMaleMiddle AgedRespiratory Function TestsAdultProspective StudiesAgedHypertension, Pulmonary

Stichwörter der Autor:innen

ILDMRIlungssclerodermasystemic sclerosisxenon

Substanzen

Xenon

Autor:innen und Institutionen

  • Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Internal Medicine Residency Program, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Bioengineering Program, University of Kansas, Lawrence, Kansas, USA.
  • Division of Allergy, Clinical Immunology, and Rheumatology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Hoglund Biomedical Imaging Center, University of Kansas Medical Center, Kansas City, Kansas, USA.

ORCID-Profile: Steven Haworth, Jiwoong Choi, Mario Castro, Peter J Niedbalski

Förderung

  • American Heart Association
  • National Scleroderma Foundation

Zitieren

APA

Shaver, D., Haworth, S., Graumann, E., Frizzell, B., Lee, D. H., Choi, J., Hall, C. S., Matson, S. M., Hamblin, M., Castro, M., Schmidt, P. S., & Niedbalski, P. J. (2026). Characterization of Pulmonary Functional Abnormalities in Systemic Sclerosis Using Xenon MRI. Journal of Magnetic Resonance Imaging, 64(3), 655-666. https://doi.org/10.1002/jmri.70363

Vancouver

Shaver D, Haworth S, Graumann E, Frizzell B, Lee DH, Choi J, et al. Characterization of Pulmonary Functional Abnormalities in Systemic Sclerosis Using Xenon MRI. Journal of Magnetic Resonance Imaging. 2026;64(3):655-666. doi:10.1002/jmri.70363

BibTeX
@article{Shaver2026,
  author = {Shaver, Dawson and Haworth, Steven and Graumann, Evan and Frizzell, Bradie and Lee, David H and Choi, Jiwoong and Hall, Chase S and Matson, Scott M and Hamblin, Mark and Castro, Mario and Schmidt, Paul S and Niedbalski, Peter J},
  title = {Characterization of Pulmonary Functional Abnormalities in Systemic Sclerosis Using Xenon MRI},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2026},
  volume = {64},
  number = {3},
  pages = {655--666},
  doi = {10.1002/jmri.70363}
}
Kostenlos starten →